TrialBritish journal of clinical pharmacology2016

Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects.

Florence Namour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.